Bill > A09276

This bill establishes the "Safeguarding Reproductive Care Act," which requires the state's health commissioner to create and manage a stockpile of two specific reproductive medications, mifepristone and misoprostol, to ensure continued access to reproductive healthcare services. The commissioner must maintain the stockpile by implementing inventory management procedures, ensuring the drugs are unexpired, restocking mifepristone every five years and misoprostol every two years, and developing supply-chain management plans in consultation with healthcare agencies. The stockpile will be made available to reproductive health service providers, who must dispense the medications at no cost to patients, and distribution is limited to qualified, licensed prescribers within the state. The bill also includes a provision that if federal approval for these medications is withdrawn, the commissioner must review the impact and report recommendations to the governor and legislature for maintaining lawful access. Additionally, the bill amends education law to allow for the establishment and operation of this medication stockpile, including provisions for dispensing drugs through telehealth services or electronic prescriptions under specific regulatory guidelines.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/A9276